These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23882730)

  • 1. [Tuberuculosis annual report 2010 (10)--treatment outcomes].
    ; ;
    Kekkaku; 2013 May; 88(5):491-5. PubMed ID: 23882730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis Annual Report 2011--(4) Tuberculosis treatment and treatment outcomes].
    Kekkaku; 2013 Sep; 88(9):677-86. PubMed ID: 24298695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis annual report 2008--series 10. Treatment outcome and TB deaths].
    Research Institute of Tuberculosis, JATA
    Kekkaku; 2010 Aug; 85(8):683-6. PubMed ID: 20845689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis annual report 2009 --series 10. Treatment outcome and TB deaths].
    ; ;
    Kekkaku; 2012 May; 87(5):415-9. PubMed ID: 22696774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
    Masuyama H; Takase A; Aoki M; Shimao T
    Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic examination and treatment outcomes of new pulmonary tuberculosis cases in Istanbul dispensaries between 1998 and 2000.
    Kílícaslan Z; Oztürk F; Sarimurat N; Cuhadaroglu C; Caglar E; Erem A
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1059-63. PubMed ID: 14598965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis annual report 2012--(4) Tuberculosis treatment and outcomes].
    ; ;
    Kekkaku; 2014 Dec; 89(12):825-34. PubMed ID: 25856976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TUBERCULOSIS ANNUAL REPORT 2013--(4) Tuberculosis Treatment and Treatment Outcomes].
    ; ;
    Kekkaku; 2015 Jul; 90(7):595-604. PubMed ID: 26630730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cohort analysis for treatment outcomes TB pulmonary cases bacteriologically confirmed in Poland].
    Szczuka I
    Pneumonol Alergol Pol; 2005; 73(3):245-53. PubMed ID: 16989161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True status of smear-positive pulmonary tuberculosis defaulters in Malawi.
    Kruyt ML; Kruyt ND; Boeree MJ; Harries AD; Salaniponi FM; van Noord PA
    Bull World Health Organ; 1999; 77(5):386-91. PubMed ID: 10361755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis control in Bangladesh: success of the DOTS strategy.
    Kumaresan JA; Ahsan Ali AK; Parkkali LM
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
    Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
    Farah MG; Tverdal A; Steen TW; Heldal E; Brantsaeter AB; Bjune G
    BMC Public Health; 2005 Feb; 5():14. PubMed ID: 15698472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.
    Singla R; Khan N; Al-Sharif N; Ai-Sayegh MO; Shaikh MA; Osman MM
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):74-9. PubMed ID: 16466041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
    Unsematham S; Kateruttanakul P
    J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
    Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
    BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New cohort analysis system in new tuberculosis surveillance system in Japan].
    Hoshino H; Ohmori M; Yoshiyama T; Wada M; Yamauchi Y; Uchimura K
    Kekkaku; 2007 Dec; 82(12):897-901. PubMed ID: 18188978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.